Literature DB >> 10736554

Qualitative assessment of cause-of-injury coding in U.S. military hospitals: NATO standardization agreement (STANAG) 2050.

P J Amoroso1, G S Smith, N S Bell.   

Abstract

BACKGROUND: Accurate injury cause data are essential for injury prevention research. U.S. military hospitals, unlike civilian hospitals, use the NATO STANAG system for cause-of-injury coding. Reported deficiencies in civilian injury cause data suggested a need to specifically evaluate the STANAG.
METHODS: The Total Army Injury and Health Outcomes Database (TAIHOD) was used to evaluate worldwide Army injury hospitalizations, especially STANAG Trauma, Injury, and Place of Occurrence coding. We conducted a review of hospital procedures at Tripler Army Medical Center (TAMC) including injury cause and intent coding, potential crossover between acute injuries and musculoskeletal conditions, and data for certain hospital patients who are not true admissions. We also evaluated the use of free-text injury comment fields in three hospitals.
RESULTS: Army-wide review of injury records coding revealed full compliance with cause coding, although nonspecific codes appeared to be overused. A small but intensive single hospital records review revealed relatively poor intent coding but good activity and cause coding. Data on specific injury history were present on most acute injury records and 75% of musculoskeletal conditions. Place of Occurrence coding, although inherently nonspecific, was over 80% accurate. Review of text fields produced additional details of the injuries in over 80% of cases.
CONCLUSIONS: STANAG intent coding specificity was poor, while coding of cause of injury was at least comparable to civilian systems. The strengths of military hospital data systems are an exceptionally high compliance with injury cause coding, the availability of free text, and capture of all population hospital records without regard to work-relatedness. Simple changes in procedures could greatly improve data quality.

Entities:  

Mesh:

Year:  2000        PMID: 10736554     DOI: 10.1016/s0749-3797(00)00110-0

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  7 in total

1.  Proposed explanations for excess injury among veterans of the Persian Gulf War and a call for greater attention from policymakers and researchers.

Authors:  N S Bell; P J Amoroso; D H Wegman; L Senier
Journal:  Inj Prev       Date:  2001-03       Impact factor: 2.399

2.  Hospitalizations for fall-related injuries among active-duty Army soldiers, 1980-1998.

Authors:  Laura Senier; Nicole S Bell; Michelle M Yore; Paul J Amoroso
Journal:  Work       Date:  2002

3.  Accuracy of injury coding under ICD-9 for New Zealand public hospital discharges.

Authors:  J Langley; S Stephenson; C Thorpe; G Davie
Journal:  Inj Prev       Date:  2006-02       Impact factor: 2.399

4.  Does occupation explain gender and other differences in work-related eye injury hospitalization rates?

Authors:  Gordon S Smith; Andrew E Lincoln; Tien Y Wong; Nicole S Bell; Paul F Vinger; Paul J Amoroso; David A Lombardi
Journal:  J Occup Environ Med       Date:  2005-06       Impact factor: 2.162

5.  Causes, types and severity of injury among army soldiers hospitalized with alcohol comorbidity.

Authors:  Jonathan Howland; Nicole S Bell; Ilyssa E Hollander
Journal:  Addiction       Date:  2007-09       Impact factor: 6.526

6.  International classification of external causes of injury: a study on its content coverage.

Authors:  Leila Ahmadian; Fatemeh Salehi; Shabnam Padidar
Journal:  BMC Med Inform Decis Mak       Date:  2021-05-13       Impact factor: 2.796

7.  Nonsteroidal Anti-Inflammatory Drug Prescriptions Are Associated With Increased Stress Fracture Diagnosis in the US Army Population.

Authors:  Julie M Hughes; Craig J McKinnon; Kathryn M Taylor; Joseph R Kardouni; Lakmini Bulathsinhala; Katelyn I Guerriere; Kristin L Popp; Mary L Bouxsein; Susan P Proctor; Ronald W Matheny
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.